CD8A and neoplasm: CCR5-CCL5 inhibition has a wide range of effects on the immune response and immune cells, including preventing chemotaxis of CCR5+ macrophages and T cells, prevention of Treg migration into tumours, and blocking CD8 T cell mediated neuropathologies [32, 49, 50].